N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease

• 收藏
• 分享

专利权人:

Janssen Alzheimer Immunotherapy

发明人:

Schenk, Dale B,Bard, Frédérique,Vasquez, Nicki J,Yednock, Ted

申请号：

NO20015773

公开号：

NO337301B1

申请日:

2001.11.27

申请国别(地区):

NO

年份:

2016

代理人:

摘要：

The invention provides improved agents and methods for treatment of diseases associated with amyloid deposits of A² in the brain of a patient. Such methods entail administering agents that induce a beneficial immunogenic response against the amyloid deposit. The methods are useful for prophylactic and therapeutic treatment of Alzheimer's disease. Preferred agents including N-terminal fragments of A² and antibodies binding to the same.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/